β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians
about
Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectivesLixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-AnalysisFeatures of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values.Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed mealDoes the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus.Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trialDapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3).Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial.One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study.Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation.A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes.Investigational insulin secretagogues for type 2 diabetes.Metformin: New Preparations and Nonglycemic Benefits.Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies.Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study.Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study).Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.Beta-cell replacement strategies for diabetes.Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label,High genetic risk scores for impaired insulin secretory capacity doubles the risk for type 2 diabetes in Asians and is exacerbated by Western-type diets.Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes.Regulation of glucose metabolism in non-diabetic, metabolically-obese normal-weight Asians.Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial.A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes.A Point System for Predicting 10-Year Risk of Developing Type 2 Diabetes Mellitus in Japanese Men: Aichi Workers' Cohort Study.Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study.Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs.Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey.A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects.
P2860
Q26749165-E93935D8-DA2B-43F3-AAC7-13706E8C17B6Q31140045-D3BE7165-E75A-4C0C-B8A2-E95F2A9C8BE5Q33685615-5E6E551D-F830-49D2-B907-848ECBDF77FCQ36148983-29FA1118-D9D1-4090-B506-E7ACD3348472Q36498707-9F9D0E0D-B487-4C16-B35B-760EB2CA5E45Q36547683-85465346-DBA7-4355-83C9-7A818BF403E8Q36717000-CEED8D92-3BDD-4027-9E0F-92508ABCC165Q37286787-BAC3F530-CDBF-4BA6-8F62-D7300E7399DEQ37586607-D93DE0E3-EA46-47C4-B75B-33AC0A5EEB67Q37639310-1D33F49D-733C-4681-A07E-E4903C0759F6Q37677886-1A1551D3-9C2C-4AD1-8F29-47FDFB83B3CAQ37696575-84CF192B-6836-4985-A5D6-2F30715CAB3DQ38408520-0B543584-55CB-4C59-9FBD-06C501BD2329Q38647717-D316ACB5-3BAC-4325-B6F6-8943474C006FQ38694894-94E55AE0-98C7-454B-B2C0-60242FEA8FD6Q38735419-EB95D0AB-32FC-4DB8-B50B-257F71DC7405Q39100209-BCBC6469-6C23-49C3-ABEC-401D75A99A47Q39108666-17428D38-B7D5-42E6-8F9E-056155F06129Q40113914-16DDBAB2-247E-4C65-BA14-F63897B9CB59Q40557047-481139A6-8786-4C8D-A2FB-F88AA10897C3Q42699213-D18E1C5F-FE83-4224-8E2A-B64700B9ECD5Q43187617-66F7EF16-99D5-4A23-BE27-EA9B6654D622Q46686457-34BDADD3-98B6-4712-B49E-5241D8E7B163Q47367938-CF9E8893-242F-4DB1-BCA2-CE976A72B73EQ47596092-29F862B8-5579-4F3A-A916-50C560BCEF70Q48031376-C28B273D-C874-436C-B585-353CDBCBBD72Q48147721-2A106116-FB89-4984-B050-6C6DB11DF367Q48162160-CF4FB3D1-FB4B-43D9-A98D-5F7D084282B8Q49630231-11DC277F-CF26-4D7C-8E71-B6FD4A748DB5Q49917632-C31247C6-A447-47BE-92B6-52F4186DB008Q50044622-6AD6898D-867B-467A-8727-4C1D12BC5131Q50050575-D12DBB5C-6FB6-4DD9-AF70-75717C8E550AQ50351054-5912CE11-8A83-48A2-A6C1-20036F29D537Q51244515-F0D5D6DD-E900-4142-B6C5-B62B961EF825Q51244521-6F4DE53B-92A5-4A75-A597-666E7C857E96Q51244960-88192660-5E1F-4B75-93BC-EA119B610C5EQ51246350-C6EE38B5-3367-4FD7-AC2C-D12B558331CCQ51276253-2481C171-0020-48A6-9C5A-6FE972EE057CQ52562274-094F040A-44C2-447B-81A6-BA64938E6E6FQ52656812-4AA32D13-6039-4C44-A240-21EDF22E9089
P2860
β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@ast
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@en
type
label
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@ast
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@en
prefLabel
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@ast
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@en
P2093
P2860
P921
P1476
β cell dysfunction versus insu ...... type 2 diabetes in East Asians
@en
P2093
Mitsuo Fukushima
Susumu Seino
Yutaka Seino
P2860
P2888
P356
10.1007/S11892-015-0602-9
P50
P577
2015-06-01T00:00:00Z